KKR (KKR) has become Morgan Stanley's top pick instead of CME Group (CME) amid improving macroeconomic conditions and normalizing volatility, Morgan Stanley said in a note e-mailed Thursday.
"A capital markets rebound that's back on track is set to reaccelerate the private markets flywheel, supporting a robust earnings outlook for KKR," the brokerage said in a note to clients.
The private-equity giant's diversity across end markets is best placed to take advantage of "secular tailwinds" across private credit, infrastructure, private wealth, and insurance that back an outlook for a double-digit growth, Morgan Stanley said.
"We still see CME as a defensive beneficiary of uncertainty that may persist, but macro conditions have trended better than feared and volatility has since normalized from early 2Q levels," the brokerage said.
Morgan Stanley reiterated its overweight rating on the KKR stock, with a $150 price target.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。